About Takeda Oncology
We aspire to cure cancer, with inspiration from patients and innovation from everywhere.
At Takeda Oncology, we aspire to cure cancer, with inspiration from patients and innovation from everywhere. Our leadership in oncology extends more than 25 years and includes a range of therapies that have helped to transform the treatment landscape for previously underserved patient populations, in some cases shifting paradigms and becoming standard of care. We are building on our portfolio of approved medicines for hematologic cancers and solid tumors and advancing a cutting-edge pipeline focused on the power of innate immunity. We aim to introduce new classes of immunotherapies that can lead to deep, durable responses so that more patients can benefit from – and have access to – innovative medicines.
About Takeda Oncology, Transforming Hope into Action
Takeda Oncology, the Global Oncology Business Unit of Takeda Pharmaceutical Company
Takeda Oncology, headquartered in Cambridge, Massachusetts, has hubs in 10 countries; United States, Japan, Germany, Spain & Portugal, France, Italy, the United Kingdom/Ireland and Canada
R&D center is in Cambridge, MA, United States
Manufacturing centers are in five countries: Ireland, Austria, Russia, Japan and United States